Status:
UNKNOWN
Cough Count Validation
Lead Sponsor:
KarmelSonix Ltd.
Conditions:
Chronic Cough
Eligibility:
All Genders
2-80 years
Brief Summary
People with respiratory infection, asthmatic patients and cystic fibrosis (CF) patients suffer from a multitude of pathologies of airways and are often inflicted with chronic cough. Treatment of coug...
Detailed Description
Cough is part of the defense mechanism to protect the lung from foreign particles and remove secretions from the airways . While the cough reflex is essential in protecting the lung from foreign mater...
Eligibility Criteria
Inclusion
- Age 2-80 years.
- Patients with significant chronic cough.
- Patients in hemodynamic stability. Patient is not in respiratory distress.
- Subject or subject's parents/guardians is able to comprehend and give informed consent for participation in the study.
Exclusion
- Contraindication to the use of the PulmoTrack™ or performing ARM (Acoustic Respiratory Monitoring).
- Hemodynamic instability and/or SOB.
- Concurrent additional major illness.
- Concurrent participation in any other study.
- Physician objection
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01413698
Start Date
September 1 2011
End Date
September 1 2012
Last Update
August 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, Israel, 91120